BCR-ABL1-Negative Chronic Myeloproliferative Neoplasms and Pulmonary Hypertension: A Prospective Long-Term Follow-up Study of the Impact of Pulmonary Hypertension on Survival

Payzin K. B., Savasoglu K., ALACACIOĞLU İ., Dalgic E. E., Kucukzeybek B. B., Calli A. O., ...More

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol.21, no.2, pp.125-131, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 21 Issue: 2
  • Publication Date: 2021
  • Doi Number: 10.1016/j.clml.2020.08.006
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Page Numbers: pp.125-131
  • Keywords: Essential thrombocythemia, JAK2 mutation, Polycythemia vera, Primary myelofibrosis, Pulmonary hypertension, ARTERIAL-HYPERTENSION, DIAGNOSIS, MYELOFIBROSIS, SECONDARY
  • Dokuz Eylül University Affiliated: Yes


This prospective study assessed the prevalence of pulmonary hypertension (PHT) related to chronic myeloproliferative neoplasms (CMPNs) and evaluated the impact of PHT on survival during long-term follow-up. In a large group of BCR-ABL1-negative CMPN patients, there was a low prevalence of PHT. The impact of PHT on survival was negligible.